Shandong Sinoglory Health (603182) - Net Assets
Based on the latest financial reports, Shandong Sinoglory Health (603182) has net assets worth CN¥1.13 Billion CNY (≈ $165.73 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.39 Billion ≈ $203.79 Million USD) and total liabilities (CN¥260.09 Million ≈ $38.06 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 603182 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.13 Billion |
| % of Total Assets | 81.32% |
| Annual Growth Rate | 23.24% |
| 5-Year Change | 136.16% |
| 10-Year Change | N/A |
| Growth Volatility | 39.61 |
Shandong Sinoglory Health - Net Assets Trend (2020–2025)
This chart illustrates how Shandong Sinoglory Health's net assets have evolved over time, based on quarterly financial data. See 603182 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Shandong Sinoglory Health (2020–2025)
The table below shows the annual net assets of Shandong Sinoglory Health from 2020 to 2025. For live valuation and market cap data, see Shandong Sinoglory Health (603182) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.11 Billion ≈ $161.74 Million |
+2.79% |
| 2024-12-31 | CN¥1.08 Billion ≈ $157.35 Million |
+4.49% |
| 2023-12-31 | CN¥1.03 Billion ≈ $150.60 Million |
+6.56% |
| 2022-12-31 | CN¥965.76 Million ≈ $141.32 Million |
+106.35% |
| 2021-12-31 | CN¥468.02 Million ≈ $68.49 Million |
+20.35% |
| 2020-12-31 | CN¥388.87 Million ≈ $56.90 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Shandong Sinoglory Health's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 140.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥485.72 Million | 43.95% |
| Other Components | CN¥619.57 Million | 56.05% |
| Total Equity | CN¥1.11 Billion | 100.00% |
Shandong Sinoglory Health Competitors by Market Cap
The table below lists competitors of Shandong Sinoglory Health ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
PRUKSA HOLDING
BK:PSH-R
|
$298.84 Million |
|
Bermaz Auto Bhd
KLSE:5248
|
$298.95 Million |
|
Tellgen Corp
SHE:300642
|
$298.98 Million |
|
Shanghai DOBE Cultural & Creative Industry Development (Group) Co. LTD.
SHE:300947
|
$299.01 Million |
|
Dasheng Times Cultural Investment Co Ltd
SHG:600892
|
$298.82 Million |
|
ALPHA
KLSE:0303
|
$298.81 Million |
|
DI Dong Il Corp
KO:001530
|
$298.79 Million |
|
Viva Biotech Holdings
F:VB0
|
$298.64 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shandong Sinoglory Health's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,075,317,845 to 1,105,285,399, a change of 29,967,554 (2.8%).
- Net income of 94,700,621 contributed positively to equity growth.
- Dividend payments of 66,040,510 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥94.70 Million | +8.57% |
| Dividends Paid | CN¥66.04 Million | -5.97% |
| Other Changes | CN¥1.31 Million | +0.12% |
| Total Change | CN¥- | 2.79% |
Book Value vs Market Value Analysis
This analysis compares Shandong Sinoglory Health's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.85x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 3.94x to 1.85x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | CN¥3.15 | CN¥12.41 | x |
| 2021-12-31 | CN¥3.79 | CN¥12.41 | x |
| 2022-12-31 | CN¥5.87 | CN¥12.41 | x |
| 2023-12-31 | CN¥6.25 | CN¥12.41 | x |
| 2024-12-31 | CN¥6.53 | CN¥12.41 | x |
| 2025-12-31 | CN¥6.72 | CN¥12.41 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shandong Sinoglory Health utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.57%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 6.83%
- • Asset Turnover: 1.01x
- • Equity Multiplier: 1.24x
- Recent ROE (8.57%) is below the historical average (12.87%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 19.05% | 7.65% | 1.54x | 1.62x | CN¥35.20 Million |
| 2021 | 16.91% | 6.41% | 1.53x | 1.72x | CN¥32.35 Million |
| 2022 | 11.84% | 7.09% | 1.36x | 1.23x | CN¥17.81 Million |
| 2023 | 10.70% | 6.50% | 1.32x | 1.25x | CN¥7.22 Million |
| 2024 | 10.15% | 7.33% | 1.04x | 1.33x | CN¥1.60 Million |
| 2025 | 8.57% | 6.83% | 1.01x | 1.24x | CN¥-15.83 Million |
Industry Comparison
This section compares Shandong Sinoglory Health's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $2,082,192,569
- Average return on equity (ROE) among peers: 2.81%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shandong Sinoglory Health (603182) | CN¥1.13 Billion | 19.05% | 0.23x | $298.82 Million |
| Shenzhen Shenbao Industrial Co Ltd (000019) | $372.94 Million | 1.53% | 0.77x | $992.25 Million |
| Hainan Pearl River Holdings Co Ltd (000505) | $399.64 Million | -9.56% | 0.79x | $515.34 Million |
| Xiwang Foodstuffs Co Ltd (000639) | $135.06 Million | 5.79% | 0.97x | $206.92 Million |
| Nanfang Black Sesame Group Co Ltd (000716) | $199.49 Million | -32.62% | 2.81x | $473.73 Million |
| CNFC Overseas Fishery Co Ltd (000798) | $796.52 Million | 0.36% | 0.09x | $400.45 Million |
| Henan Shuanghui Investment & Development Co Ltd (000895) | $16.36 Billion | 24.69% | 0.34x | $11.55 Billion |
| Xinjiang Chalkis Co Ltd (000972) | $767.56 Million | 1.47% | 1.57x | $388.25 Million |
| Zhengzhou Qianweiyangchu Food Co Ltd (001215) | $405.77 Million | 18.27% | 1.07x | $599.98 Million |
| Qingdao Foods Co Ltd (001219) | $923.11 Million | 9.90% | 0.10x | $351.80 Million |
| Shandong Oriental Ocean Sci-Tech Co Ltd (002086) | $461.01 Million | 8.31% | 0.83x | $507.38 Million |
About Shandong Sinoglory Health
Shandong Sinoglory Health Food Co., Ltd. manufactures soy proteins in China. The company offers soy protein isolate, concentrate, low-temperature edible soybean meal, soybean oil, and soy dietary fiber products. It also exports its products. The company serves in the United States, the European Union, and Australia. Shandong Sinoglory Health Food Co., Ltd. was founded in 2000 and is based in Liao… Read more